Current Gold Standards for MSI Testing and the Clinical Relevance of the MSI-H Biomarker

This webinar explores the complexities of the vaginal microbiome and new opportunities for Next-Gen Sequencing in women's health diagnostics.

The era of affordable sugars, renewable biochemical and bio-based materials from lignocellulosic feedstock are here. Enabling a paradigm shift from petroleum and change over to renewable biomass, the new fractionation technologies of lignin allow the entire biomass to be utilized. Lignocellulosic biomass – a variety of non-edible, woody materials – is the largest renewable reservoir of fermentable carbohydrates, aromatic compounds, and other chemical building blocks. With the new wave of biotechnology, controlled size, solubility, and activity of lignin can be achieved.

When assessing a potential biological therapeutic candidate, several histopathological technologies are typically employed. This ensures the target expression is validated in both normal and diseased tissues before proceeding with pre-clinical studies. Protein B is a transmembrane glycoprotein that is overexpressed in numerous cancers, including triple-negative breast cancer and is often correlated with the metastatic phenotype. In this GEN webinar, we will discuss the process involved in a typical molecular pathology laboratory. Control cell lines and the RNAScope® Assay were utilized to validate the immunohistochemistry protocol.

Despite exciting recent developments in neuroscience, identifying novel, truly effective treatments for patients with neurological and psychiatric conditions remains highly challenging. There is a high unmet need for more translational models and advanced analytical techniques that afford greater biological insight and productivity.